Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes
Yaron Arbel(Tel Aviv Sourasky Medical Center), Shlomo Berliner(Tel Aviv University), Jessia Benhorin(Tel Aviv University), Shmuel Banai(Tel Aviv Sourasky Medical Center), Amir Halkin(Tel Aviv University), Ariel Finkelstein, Gad Keren(Assuta Medical Center), Itzhak Herz(Tel Aviv University), Saul Yedgar(Hebrew University of Jerusalem), Gershon Barashtein(Hebrew University of Jerusalem)
Cited by 32
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347